{"id":"NCT04772534","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)","officialTitle":"A Phase 3, Open-label Clinical Study to Evaluate the Immunogenicity and Safety of 9vHPV Vaccine, in Japanese Boys and Girls, 9 to 15 Years of Age.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-17","primaryCompletion":"2024-04-06","completion":"2024-04-06","firstPosted":"2021-02-26","resultsPosted":"2025-05-30","lastUpdate":"2025-05-30"},"enrollment":314,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Papillomavirus Infections"],"interventions":[{"type":"BIOLOGICAL","name":"9vHPV vaccine","otherNames":["V503","SILGARD®9","GARDASIL™9"]}],"arms":[{"label":"3-dose in 9 to 15 year old boys","type":"EXPERIMENTAL"},{"label":"2-dose in 9 to 14 year old boys","type":"EXPERIMENTAL"},{"label":"2-dose in 9 to 14 year old girls","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is the estimation of the human papillomavirus (HPV) 6, 11, 16, 18, 31, 33, 45, 52 and 58 seroconversion at 1 month post last dose (Month 7) following 3 doses and 2 doses of the 9-valent human papillomavirus (9vHPV) vaccine. No hypothesis will be tested since this study is an estimation-only study.","primaryOutcome":{"measure":"Seroconversion Percentages for the HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58","timeFrame":"1 month after final dose (Month 7)","effectByArm":[{"arm":"3-Dose Regimen: 9 to 15 Year Old Boys","deltaMin":100,"sd":null},{"arm":"2-dose Regimen: 9 to 14 Year Old Boys","deltaMin":100,"sd":null},{"arm":"2-dose Regimen: 9 to 14 Year Old Girls","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"9 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":15},"locations":{"siteCount":12,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://www.merckclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":103},"commonTop":["Pyrexia","Headache","Nasopharyngitis"]}}